LIBTAYO conc perf 350 mg/7ml flac 7 ml
7680670940023
CH-67094
L01FF06
07.16.1.
Reimbursement limitations:
LIBTAYO.01
Cancer bronchopulmonaire non à petites cellules (CBNPC)
Libtayo en monothérapie est indiqué pour le traitement …
1 / 3
google
Details
- Product number
- 6709402
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- cemiplimabum 350 mg, histidinum, histidini hydrochloridum monohydricum, saccharum, prolinum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 7 ml.
Articles (1)
Libtayo 350 mg/7 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
350.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 3811.00
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2022
Authorization holder
Regeneron Switzerland GmbH
4052 Basel
Authorization information
- Swissmedic authorization number
- 67094
- Drug name
- Libtayo, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FF06
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 27/05/2020
- Authorization expiration date
- 04/10/2027
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LIBTAYO conc perf 350 mg/7ml flac 7 ml
- Description (DE)
- LIBTAYO Inf Konz 350 mg/7ml Durchstf 7 ml
- Market launch
- 27/05/2020
- Narcotic (BTM)
- No